• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Primary Sclerosing Cholangitis
Tags
  • Primary Sclerosing Cholangitis
Study title A Randomized, Double-blind, Dose-ranging, Placebo-controlled, Phase 2a Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Primary Sclerosing Cholangitis (PSC) and Suspected Liver Fibrosis (INTEGRIS-PSC)
Disease or condition Primary sclerosing cholangitis
Study type Interventional  (Clinical Trial)
Intervention/treatment PLN-74809 or placebo
Phase 3
Study site Duke University
Study location Durham
Principal investigator name Andrew Muir
Study coordinator name and email Adele Gaskin, adele.gaskin@duke.edu
Phone contact 919-684-0742
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04480840

 

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE